News
Authoritative Release! Varieties of non-reference preparations ushered in imitation!
In order to meet the clinical needs of patients and ensure the safety, effectiveness and controllable quality of drugs, applicants are encouraged to select the varieties included in the catalog of reference preparations published by the national drug regulatory authorities for generic research.
【October Nanjing API】Xinherui Biotech sincerely invites you to visit
The 89th China Pharmaceutical API/Intermediates/Packaging/Equipment Fair (API China) and the 27th China International Pharmaceutical (Industry) Exhibition and Technology Exchange (CHINAPHARM) will be held at Nanjing International Expo Center on October 18-20.
CDE: After the first variety passed the consistency evaluation, it will no longer accept the consistency evaluation application of the same variety from other drug manufacturers after three years!
Notice on publicly soliciting opinions on the “Guidelines for the Acceptance and Review of Consistency Evaluation of the Quality and Efficacy of Generic Drugs (Draft for Solicitation of Comments)”.
Honors l Boan Biotech awarded Xinherui the title of “Excellent Supplier”.
Thanks to Boan Biotech for awarding Xinherui“Excellent supplier in 2022”Title. In the future, Xinherui will continue to work together with Boan Biotech for win-win cooperation. In order to promote China’s
Xinherui Biotech passed the ISO9001:2015 quality management system certification
Good news：Xinherui Biotech successfully passed the ISO9001:2015 quality management system certification. In order to further standardize the company’s business processes, effectively control risks, and form standardized operation and standardized management,
